Golden Recursion Inc. logoGolden Recursion Inc. logo
Advanced Search
Mendel.ai

Mendel.ai

Mendel.ai is a life science company offering an artificial intelligence platform to aid clinical experts improve their clinical cancer research.

Overview

Mendel.ai is a life science company offering an artificial intelligence platform to aid clinical experts improve their clinical cancer research that is headquartered in San Jose, California and was founded in 2016 by Karim Galil, Ruchi Deshpande, and Wael Salloum. The AI platform is named "Mendel Brain" and is made to aid clinicians in all aspects of clinical trial research. The company claims Mendel Brain allows querying of medical records, skimming through scientific papers, help with feasibility surveys, and augmenting screening processes.

Funding
Convertible note

On November 2, 2016 Mendel.ai announced receiving a convertible note from SOSV and IndieBio for an undisclosed amount.

Seed

On July 1, 2017 Mendel.ai announced raising $2 million in funding from DCM Ventures, Bootstrap Labs, and Launch Capital. The company plans on using their seed funding to begin implementing their Mendel Brain product in hospitals and cancer genomics companies. At the time of announcing their seed funding, Mendel.ai began working with the Comprehensive Blood & Cancer Center (CBCC) in Bakersfield, California to help the center match patients with doctors and clinical trials for treating cancer.

Timeline

April 21, 2022
Mendel.ai raises a $40,000,000 series B round from DCM Ventures and Oak HC/FT.
June 7, 2021
Mendel.ai raises a $18,000,000 series A round from Bootstrap Labs, DCM Ventures, Millennium Technology Value Partners and SOSV.
November 2019
Mendel.ai raises a $3,000,000 seed round from DCM Ventures.
June 2018
Mendel.ai raises a $2,400,000 seed round from BootstrapLabs and DCM Ventures.
July 2017
Mendel.ai raises a $2,000,000 seed round from Bootstrap Labs, DCM Ventures, DeNa Strategic Investments, LaunchCapital and Mark H Goldstein.

Funding Rounds

Patents

Further Resources

Title
Author
Link
Type
Date

John Lee, Partner at JAZZ Venture Partners on Patientless Podcast #007

Web

Golden logo
By using this site, you agree to our Terms & Conditions.